Michael Pudaloff
The long-term use of psychotropic medication in community mental health care raises important public health questions regarding patient safety, governance, and accountability. This paper presents a case-based analysis of potential iatrogenic harm arising at the intersection of mental health services and adult social care in England. Using the long-term experience of an older woman exposed to prolonged neuroleptic treatment and subsequent residential placement, the paper examines how diagnostic uncertainty, risk-based psychiatric practice, and commissioning-driven social care systems can interact to produce avoidable dependency, functional decline, and loss of autonomy. Drawing on contemporary psychiatric, neurological, and policy literature, the analysis situates this experience within wider structural challenges. These include the continuing absence of definitive biological markers for many psychiatric diagnoses, the recognised neurological risks associated with prolonged dopamine-blocking medication, and the organisational and financial pressures that shape modern health and social care provision. A parallel geriatric case is included to illustrate how similar patterns of pharmacological containment and functional decline may arise across different care settings. Taken together, the cases suggest that adverse outcomes may emerge not solely from individual clinical decisions but from structural features of care delivery, including fragmented oversight between clinical services and social care commissioning. The paper argues that current frameworks can, at times, prioritise institutional risk management over patient-centred recovery. It concludes that stronger governance mechanisms—particularly clearer review structures, improved informed consent processes, and greater transparency at the mental health–social care interface—may be required to reduce the risk of long-term medication-related harm.